Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi promised pandemic hazard pay to vaccine plant workers, then offered 3 days off instead, lawsuit says
Fierce Pharma
Wed, 12/16/20 - 12:43 pm
Tags:
Sanofi, drug manufacturing, COVID-19, vaccines, pandemic
Weak clinical data force Sanofi, GSK to delay COVID-19 vaccine
Fierce Biotech
Fri, 12/11/20 - 11:27 am
Tags:
Sanofi, GSK, vaccines, COVID-19, clinical trials
Sanofi accepts a lengthy delay as its hemophilia drug fitusiran resumes a PhIII after safety fears forced a halt
Endpoints
Thu, 12/10/20 - 07:20 pm
Tags:
Sanofi, fitusiran, FDA, hemophilia
Rilzabrutinib granted FDA fast track designation for treatment of immune thrombocytopenia
Pharmaceutical Business Review
Thu, 11/19/20 - 10:40 am
Tags:
rilzabrutinib, fast track, FDA, Sanofi, Principia Biopharma, chronic immune thrombocytopenia
FDA to expedite development of two Sanofi rare disease drugs
Pharmaforum
Thu, 11/19/20 - 10:23 am
Tags:
Sanofi, FDA, Rare Diseases, Pompe disease, Avalglucosidase alfa
Sanofi grapples with rejection of potential first-in-class orphan drug, faults third-party manufacturing
Endpoints
Mon, 11/16/20 - 10:25 am
Tags:
Sanofi, sutimlimab, orphan drugs, FDA, drug manufacturing
France’s Medicine Watchdog Indicted Over Sanofi’s Birth Defect-Causing Drug
BioSpace
Sat, 11/14/20 - 02:00 pm
Tags:
Sanofi, Depakine, France, epilepsy
Doubling down on Sanofi's French roots, Paul Hudson infuses €50M into Jeito Capital to boost homegrown biotechs
Endpoints
Fri, 11/13/20 - 12:27 pm
Tags:
Paul Hudson, Sanofi, Jeito Capital
Pfizer's COVID-19 vaccine looks impressive, but Sanofi, J&J and Novavax shots eye a logistics edge
Fierce Pharma
Wed, 11/11/20 - 11:07 pm
Tags:
Pfizer, Sanofi, JNJ, Novavax, vaccines, COVID-19, distribution
Sanofi/Alnylam’s haemophilia drug hits another safety speed-bump
Pharmaforum
Mon, 11/9/20 - 10:59 am
Tags:
hemophilia, Sanofi, Roche, fitusiran
Sanofi inks $358M Kiadis takeover to acquire NK-cell platform
Fierce Biotech
Mon, 11/2/20 - 10:48 am
Tags:
Sanofi, Kiadis, M&A, Sarclisa, natural killer cell therapy
Go or no go? Big decisions loom for Bristol and Sanofi
EP Vantage
Fri, 10/30/20 - 10:12 am
Tags:
FDA, Bristol-Myers Squibb, aducanumab, Sanofi, sutimlimab, Y-mAbs, Danyelza
Sanofi, despite COVID-19, sees early gains from CEO Hudson's strategy revamp
Fierce Pharma
Thu, 10/29/20 - 12:19 pm
Tags:
Sanofi, earnings, Dupixent, Paul Hudson, Pharma CEOs
Watch out, Merck: FDA grants Regeneron, Sanofi's Libtayo priority review for coveted first-line use in lung cancer
Fierce Pharma
Thu, 10/29/20 - 12:17 pm
Tags:
Regeneron, Sanofi, Libtayo, FDA, priority review, non-small cell lung cancer, Merck, Keytruda
Sanofi to Evaluate THOR-707 with Merck's Checkpoint Inhibitor Keytruda
BioSpace
Thu, 10/29/20 - 12:14 pm
Tags:
Sanofi, Merck, THOR-707, Keytruda, solid tumors
Sanofi, GSK pledge 200M doses to an international coronavirus vaccine alliance
BioPharma Dive
Wed, 10/28/20 - 12:19 pm
Tags:
Sanofi, GSK, COVID-19, vaccines, COVAX
Sanofi, Regeneron chase 4th Dupixent approval with rare esophageal disease data
Fierce Pharma
Mon, 10/26/20 - 11:04 pm
Tags:
Sanofi, Regeneron, FDA, Dupixent, eosinophilic esophagitis
Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report
Fierce Pharma
Mon, 10/19/20 - 10:39 am
Tags:
Sanofi, inflammation, layoffs
COVID-19 mRNA vaccine candidate from Sanofi and Translate protects mice, monkeys: study
Fierce Biotech
Thu, 10/15/20 - 10:41 pm
Tags:
Sanofi, Translate Bio, MRNA, vaccines, COVID-19
Dupixent Posts Positive Results in Phase III Pediatric Asthma Study
BioSpace
Tue, 10/13/20 - 11:06 am
Tags:
Regeneron, Sanofi, pediatric, asthma, clinical trials, Dupixent

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.